Andrew Witty

Andrew Witty is a British businessman and the current Chief Executive Officer (CEO) of UnitedHealth Group, a diversified health care company based in the United States. Prior to this, he served as the CEO of GlaxoSmithKline (GSK), a British multinational pharmaceutical company, from 2008 to 2017.

Early Life and Education

Andrew Witty was born in 1964 in the United Kingdom. He attended the University of Nottingham, where he earned a degree in economics.

Career

Witty joined GlaxoSmithKline in 1985, starting his career in the company's sales and marketing department. He held various leadership roles in the company, including Senior Vice President for Asia Pacific and Director of Marketing for Europe. In 2008, he was appointed as the CEO of GSK, a position he held until 2017.

During his tenure as CEO, Witty focused on diversifying GSK's product portfolio, expanding the company's presence in emerging markets, and promoting ethical practices within the pharmaceutical industry. He also led the company's efforts to develop a vaccine for malaria, which was approved by the European Medicines Agency in 2015.

In 2017, Witty joined UnitedHealth Group as the CEO. Under his leadership, the company has continued to expand its healthcare services and improve its operational efficiency.

Honours and Awards

In 2012, Witty was knighted for his services to the economy and the UK pharmaceutical industry. He has also received honorary degrees from the University of Nottingham and the University of London.

Personal Life

Witty is married and has two children. He is known for his philanthropic work, particularly in the area of global health.

See Also

• GlaxoSmithKline
• UnitedHealth Group
• Pharmaceutical industry in the United Kingdom